Everon Biosciences Overview
- Founded
-
2010
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Everon Biosciences General Information
Description
Developer of innovative anti-aging medicines designed to prevent age-related diseases. The company's medicines are prepared for selective elimination of senescent cells and injection of pharmacological agents that can block or slow down the generation of age-related waste products, enabling people to find a cure for Systemic Aging Syndrome and age-related pathologies.
Contact Information
Website
www.everonbio.com
Formerly Known As
Tartis Aging
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 640 Ellicott Street
- Suite 444
- Buffalo, NY 14203
- United States
+1 (716) 000-0000
Everon Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 01-Mar-2021 | 00.000 | Completed | Startup | ||
| 3. Grant | 06-Feb-2013 | 000 | 00.000 | Completed | Startup | |
| 2. Debt - General | 19-Aug-2011 | $3.86M | Completed | Startup | ||
| 1. Early Stage VC | 01-Jan-2010 | $3.86M | $3.86M | Completed | Startup |
Everon Biosciences Patents
Everon Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20130310416-A1 | Methods and compositions for preventing or treating age-related diseases | Abandoned | 16-Aug-2006 | 0000000000 | |
| US-20130102569-A1 | Methods and compositions for preventing or treating age-related diseases | Abandoned | 16-Aug-2006 | 0000000000 | 0 |
| US-20100081681-A1 | Methods and compositions for preventing or treating age-related diseases | Abandoned | 16-Aug-2006 | A61K31/436 |
Everon Biosciences Executive Team (5)
Everon Biosciences Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Everon Biosciences Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Skolkovo Foundation | Limited Partner | 000 0000 | 000000 0 |
Everon Biosciences Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 000000 | 06-Aug-2018 | 00000 0000 | 0000 | Drug Discovery |